ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "socioeconomic factors"

  • Abstract Number: 1842 • ACR Convergence 2025

    Social Vulnerability Index, Type 2 Lupus Symptoms, and Select Dysregulated Immune Features Identify Stage 2 (Pre-classification) SLE in the Lupus Autoimmunity in Relatives (LAUREL) Follow-up Cohort

    Melissa Munroe1, Zoe Reed2, Joel Guthridge2, Diane Kamen3, Timothy Niewold4, Kendra Young5, Angel Weng5, Emma Wu5, Gary Gilkeson6, Michael Weisman7, Mariko Ishimori7, Daniel Wallace8, John Harley9, David Karp10, Jill Norris11 and Judith James2, 1Oklahoma Medical Research Foundation; Progentec Diagnostics, Inc., Oklahoma City, OK, 2Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Medical University of South Carolina, Johns Island, SC, 4Hospital for Special Surgery, New York, New York, 5Colorado School of Public Health, Aurora, CO, 6Medical University of South Carolina, Charleston, SC, 7Cedars-Sinai Medical Center, LOS ANGELES, CA, 8Cedars Sinai Medical Center, Studio City, CA, 9US Department of Veterans Affairs Medical Center, Cincinnati, OH, 10UT Southwestern Medical Center, Dallas, TX, 11Colorado School of Public Health, Denver, CO

    Background/Purpose: Socioeconomic environmental factors are associated with SLE disease activity and early mortality and may contribute to disease progression in at-risk populations. Blood relatives (BRs)…
  • Abstract Number: 1068 • ACR Convergence 2025

    Association Between Social Determinants of Health Domains and COVID-19-Related Hospitalization in Individuals with Autoimmune Rheumatic Diseases: A Retrospective Analysis of National U.S. Data

    Londyn Robinson1, jerrod anzalone2, Jasvinder Singh3, Kaleb Michaud2, Lesley Jackson4, Maria I. ("Maio") Danila5, Dongmei Li6, Rena Patel4 and Namrata Singh7, 1University of Washington, Seattle, WA, 2University of Nebraska Medical Center, Omaha, NE, 3Baylor College of Medicine, Houston, TX, 4University of Alabama at Birmingham, Birmingham, AL, 5University of Alabama at Birmingham (UAB), Birmingham VA Medical Center, Birmingham, AL, 6University of Rochester School of Medicine and Dentistry, Rochester, NY, 7University of Washington, Bellevue, WA

    Background/Purpose: Although studies have been published on the baseline characteristics of patients with autoimmune rheumatic diseases (AIRDs) with COVID-19 infection, little data exists on how…
  • Abstract Number: 1705 • ACR Convergence 2025

    Associations Between Social Risk Factors and Acute Care Use Among Patients with Rheumatic Conditions

    Haelynn Gim1, Leah Santacroce2, Rebecca Summit3, Karli Retzel4, Virginia Bills4, Nancy Shadick3, Sara Schoenfeld5 and Candace Feldman2, 1Harvard Medical School, Brookline, MA, 2Brigham and Women's Hospital, Boston, MA, 3Brigham & Women's Hospital, Boston, MA, 4Brigham & Women's Hospital, Boston, 5Massachusetts General Hospital, Boston, MA

    Background/Purpose: Adverse social determinants of health, or social risk factors (e.g., housing instability, food insecurity), contribute to disparities in rheumatic disease care and outcomes. Understanding…
  • Abstract Number: 1067 • ACR Convergence 2025

    Investigating Barriers to Care through Childhood Opportunity, Social Vulnerability, Area Deprivation, and Distance to Care in Pediatric Localized Scleroderma

    Karen Lin1, Yuhan Ma1, Simrat Morris2 and Kristina Ciaglia3, 1Scottish Rite for Children, Dallas, TX, 2UT Southwestern Medical Center and Scottish Rite for Children, Dallas, TX, 3UT Southwestern, Children's Medical Center, and Scottish Rite for Children, Dallas, TX

    Background/Purpose: Delays in diagnosis and treatment of pediatric localized scleroderma (LS) are common due to the under-recognition at initial presentation. While previous studies on pediatric…
  • Abstract Number: 1704 • ACR Convergence 2025

    Relationships between Neighborhood Disadvantage, Cumulative Social Disadvantage, and JIA Outcomes: A CARRA Registry Study

    William Soulsby1, John Boscardin2, Daniel Horton3, Andrea Knight4, Karine Toupin-April5 and Emily von Scheven2, 1University of California, San Francisco, San Francisco, CA, 2UCSF, San Francisco, CA, 3Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, 4Hospital for Sick Children, Toronto, ON, Canada, 5University of Ottawa, Ottawa, ON, Canada

    Background/Purpose: Social determinants of health (SDOH) operate across individual, family, and community levels. We previously demonstrated that cumulative social disadvantage, comprised of individual and family-level…
  • Abstract Number: 1060 • ACR Convergence 2025

    Demographic Risk Factors, Social Vulnerability Index, and Mortality in Patients with Systemic Lupus Erythematosus

    Christine Kim1, Katherine Mitchell2, Changyong Feng1 and Allen Anandarajah3, 1University of Rochester, Rochester, NY, 2University of Rochester, Rochester, 3University of Rochester Medical Center, Rochester, NY

    Background/Purpose: Systemic lupus erythematosus (SLE) is an autoimmune disease with multi-organ involvement that is characterized by relapses and remissions. Ethnicity, socioeconomic status, gender, age, education…
  • Abstract Number: 1690 • ACR Convergence 2025

    Environmental Heat Exposure and Risk of Systemic Lupus Erythematosus

    Jennifer Woo1, Kaitlyn Lawrence2 and Dale Sandler1, 1National Institute of Environmental Health Sciences, Durham, NC, 2DLH, Corp., Durham, NC

    Background/Purpose: Environmental heat exposures have been linked to increased morbidity and mortality. Individuals with systemic lupus erythematous (SLE) often have heat- and photo- sensitivity, which…
  • Abstract Number: 1057 • ACR Convergence 2025

    Leveraging Social Risk Factor Screening Infrastructure in Rheumatology Clinics to Respond to Rising Rates of Tuberculosis Among Individuals Experiencing Homelessness

    Rebecca Summit1, Dylan Tierney2, Taussia Boadi2, Tyler Green2, Karli Retzel2, Virginia Bills2, Nancy Shadick2, Leah Santacroce3, Sara Schoenfeld4 and Candace Feldman5, 1Brigham & Women's Hospital, Boston, MA, 2Brigham & Women's Hospital, Boston, 3Brigham and Women's Hospital, Boston, MA, 4Mass General Hospital, Boston, 5Brigham and Women's Hospital/ Harvard Medical School, Boston

    Background/Purpose: Social risk factors, such as housing instability, influence care access and outcomes in people with rheumatic conditions. In June 2022, 9 rheumatology clinics in…
  • Abstract Number: 1641 • ACR Convergence 2025

    Association of Area Socioeconomic Deprivation with Community Mobility in a Diverse Cohort of Individuals with SLE

    Laura Plantinga1, C. Barrett Bowling2, S. Sam Lim3, Patti Katz4 and Jinoos Yazdany5, 1University of California, San Francisco, San Francisco, CA, 2Duke University, Durham, NC, 3Emory University School of Medicine, Atlanta, GA, 4UCSF, San Rafael, CA, 5UCSF, San Francisco, CA

    Background/Purpose: Community mobility (the extent to which individuals move independently throughout their community) is suboptimal among those with SLE, particularly for those who are Black,…
  • Abstract Number: 0707 • ACR Convergence 2025

    When Can Support Lead to Missed Clinic Appointments in Patients with Systemic Lupus Erythematosus?

    Samiha Karim1, Gaobin Bao1, Charmayne Dunlop-Thomas1 and S. Sam Lim2, 1Emory University, Atlanta, GA, 2Emory University School of Medicine, Atlanta, GA

    Background/Purpose: People from underrepresented groups with SLE can face barriers to health care and management, including discrimination and a lack of resources and social and…
  • Abstract Number: 1638 • ACR Convergence 2025

    Comparison and Assessment of the All of Us Dataset for Epidemiologic Studies of Systemic Lupus Erythematosus (SLE) Among African American Women

    Katherine Singleton1, Sarah Smith2, Charmayne Dunlop-Thomas3, L. Quinnette King2, Lori Ann Ueberroth4, Edith Williams5, S. Sam Lim6, Bethany Wolf2, Diane Kamen7 and Paula Ramos6, 1Emory University School of Medicine, Atlants, GA, 2Medical University of South Carolina, Charleston, SC, 3Emory University, Atlanta, GA, 4Medical University of South Carolina, Charleston, 5University of Rochester Medical Center, Rochester, NY, 6Emory University School of Medicine, Atlanta, GA, 7Medical University of South Carolina, Johns Island, SC

    Background/Purpose: Health disparities in SLE are well established, with African American women being disproportionately impacted. Despite the known associations between sociodemographic and genetic factors with…
  • Abstract Number: 0633 • ACR Convergence 2025

    Diffuse Alveolar Hemorrhage in ANCA-Associated Vasculitis (AAV) and Systemic Lupus Erythematosus (SLE): A Comparative Analysis

    Sai Shanmukha Sreeram Pannala1, Medha Rajamanuri2, Srikar Sama3, Fares Saliba4, Omar Mourad5, Elizabeth Fagin6, Koushik Varma Sangaraju7, Veena Katikineni8 and Anastasia Slobodnick9, 1Northwell health/Staten Island university Hospital, new york city, NY, 2Southern Illinois University School of Medicine, Springfield, IL, 3University of California San Francisco Fresno, Fresno, CA, 4Staten Island University Hospital, Staten Island, NY, 5Zucker School of Medicine at Hofstra/Northwell at Staten Island University Hospital, Staten Island, NY, 6Staten Island University Hospital, Teaneck, NJ, 7St. Luke's University Health Network, Bethlehem, PA, 8Desert Orthopaedic and Rheumatologic Institute, Apple Valley, CA, 9Northwell, Staten Island, NY

    Background/Purpose: Diffuse alveolar hemorrhage (DAH) is a rare but severe complication in Systemic Lupus Erythematosus (SLE), occurring in up to one-third of cases at disease…
  • Abstract Number: 1633 • ACR Convergence 2025

    Social Determinants of Health and Adverse Perinatal Outcomes in Women with Rheumatic Diseases

    Andres M. Ortiz-Rios1, Fany Rocio Arevalo-Nieto1, Braulio R. Avalos-Garcia1, Mara Alejandra Ponce-Santillan1, Maria Eugenia Corral-Trujillo2, Tania Sarahi Ayala-Garcia1, Dunja Athalia Perez-Garfias1, David Alejandro Ramirez-Cantu1, Leonardo Uriel Tapia-Aguayo1, Jesus Mario Ortiz-Palafox3, Eva Abigaid Galindo-Calvillo1, Emmanuel Dominguez-Chapa4, Lorena Perez-Barbosa1, Dionicio A. Galarza-Delgado5 and Cassandra Michele Skinner-Taylor1, 1Rheumatology Service, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Nuevo Leon, Mexico, 2Universidad Autónoma de Nuevo León, Rheumatology Service, Hospital Universitario "Dr. José Eleuterio González", Monterrey, Nuevo León, México., Monterrey, Nuevo Leon, Mexico, 3Rheumatology Service, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterey, Nuevo Leon, Mexico, 4Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo León, Mexico, 5Rheumatology Service, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Mexico

    Background/Purpose: Social determinants of health (SDH) are the conditions in which individuals are born, grow, live and work. These factors (education, socioeconomic status, access to…
  • Abstract Number: 0623 • ACR Convergence 2025

    Cluster Analysis of Socioeconomic and Environmental Determinants Modifying Activity, Chronicity and Clinical Manifestations of Systemic Lupus Erythematosus in the GLADEL 2.0 Cohort

    Marco Martinez1, Karen Roberts2, Rosana Quintana3, Marina Scolnik4, Carmen Funes Soaje5, Paula Alba6, Veronica Saurit7, Mercedes Garcia8, GUILLERMO ARIEL BERBOTTO9, Inés Verónica Bellomio10, Mario Eduardo Kerzberg11, Graciela Noemi Gomez12, Cecilia Pisoni13, Vicente Juarez14, Ana Malvar15, Antonio Da Silva16, ODIRLEI MONTICIELO17, Henrique Mariz18, Francinne Ribeiro19, Eduardo Borba20, Eloisa Bonfa20, Edgard dos Reis-Neto21, Iris Guerra Herrera22, Maria Loreto Massardo23, Gustavo Aroca-Martínez24, Lorena Gómez Escorcia25, Carlos Alberto Cañas26, Gerardo Quintana-Lopez27, Carlos Toro-Gutierrez28, Mario Moreno Alvarez29, MIGUEL SAAVEDRA30, Margarita Portela Hernández31, Hilda Fragoso-Loyo32, Luis H Silveira33, Ignacio García-De la Torre34, Carlos Abud-Mendoza35, Jorge Antonio Esquivel Valerio36, Maria Isabel Acosta37, Astrid Paats38, Claudia S. Mora-Trujillo39, Manuel Ugarte-Gil40, Armando Calvo41, Roberto Muñoz-Louis42, Martin Rebella43, Alvaro Danza44, José Gomez-Puerta45, Federico Zazzetti46, Ashley Orillion47, Guillermo Pons-Estel3 and Ingris del Pilar Pelaez Ballestas48, 1HGSZ No 9, Instituto Mexicano del Seguro Social, San Luis Potosí, México, Rioverde, Mexico, 2Instituto de Investigación, Rosario, Argentina, Wyomissing, PA, 3Centro Regional de Enfermedades Autoinmunes y Reumáticas, GO-CREAR, Rosario, Argentina, Rosario, Argentina, 4Hospital Italiano de Buenos Aires, Argentina, Buenos Aires, Argentina, 5Hospital Italiano de Córdoba, Córdoba, Argentina, Cordoba, Argentina, 6Hospital Córdoba y Sanatorio Allende, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Córdoba, Argentina, Cordoba, Argentina, 7Hospital Privado Universitario de Cordoba, Córdoba, Argentina, Córdoba, Argentina, 8Hospital Interzonal General de Agudos “General San Martín” de la plata, La Plata, Argentina, 9Sanatorio Británico, Rosario, Argentina, ROSARIO, Argentina, 10Hospital Padilla, Tucumán, Argentina, San Miguel de Tucumán, Argentina, 11Hospital J.M Ramos Mejía, Buenos Aires, Argentina, CABA, Argentina, 12Instituto de Investigaciones Médicas Dr. Alfredo Lanari, Don Torcuato, Argentina, 13CEMIC Centro de Educación Médica e Investigaciones Clínicas ‘‘Norberto Quirno”, Buenos Aires, Argentina, Ciudad Autonoma Buenos Aires, Argentina, 14Hospital Señor del Milagro Salta, Salta, Argentina, Salta, Argentina, 15Organización Médica de Investigación, Buenos Aires, Argentina, 16Hospital das Clinicas da Universidade Federal de Goias, Goias, Brazil, Holzkirchen, Germany, 17Hospital de Clínicas de Porto Alegre, Universidade Federal Do Rio Grande Do Sul, Porto Alegre, Brazil, PORTO ALEGRE, Rio Grande do Sul, Brazil, 18Universidad Federal de Pernambuco, Pernambuco, Brazil, Pernambuco, Brazil, 19Hospital Universitário Pedro Ernesto - Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil, Rio De Janeiro, Rio de Janeiro, Brazil, 20Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, São Paulo, Brazil, 21Escola Paulista de Medicina / Universidade federal de São Paulo (EPM / Unifesp), São Paulo, Brazil, São Paulo, Brazil, 22Hospital del Salvador Santiago de Chile, Santiago, Chile, santiago, Chile, 23Facultad de Medicina y Ciencia, Universidad San Sebastián, Santiago, Chile, Santiago, Chile, 24Clínica de la Costa y Universidad Simón Bolívar, Barranquilla, Colombia, barranquilla, Colombia, 25Clínica de la Costa y Universidad Simón Bolívar Barranquilla, Barranquilla, Colombia, Barranquilla, Colombia, 26Fundación Valle del Lili, Universidad Icesi, Cali, Colombia, Cali, Colombia, 27Facultad de Medicina, Universidad Nacional de Colombia; Hospital Universitario Fundación Santa Fe de Bogotá; Hospital Universitario Nacional de Colombia, Bogotá, Colombia, Bogota, Colombia, 28Pontificia Universidad Javeriana de Cali, Cali, Colombia, Cali, Colombia, 29Universidad de Especialidades Espíritu Santo, Guayaquil, Ecuador, Guayaquil, Ecuador, 30Hospital de Especialidades Dr. Antonio Fraga Mouret, Centro Médico Nacional La Raza, Instituto Mexicano del Seguro Social, Mexico City, Mexico, MEXICO, Mexico, 31Hospital de Especialidades del Centro Médico Nacional SXXI, Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico, Mexico City, Mexico, 32Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, Mexico City, Mexico, 33Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico, Mexico City, Mexico, 34Centro de Estudios de Investigación Básica y Clínica, S.C., Guadalajara, Mexico, Guadalajara, Jalisco, Mexico, 35Facultad de Medicina de la Universidad Autónoma de San Luis Potosí y Hospital Central "Dr. Ignacio Morones Prieto", San Luis Potosí, Mexico, San Luis Potosí, Mexico, 36Universidad Autónoma de Nuevo León, Rheumatology Service, Hospital Universitario "Dr. José Eleuterio González", Monterrey, Nuevo León, México., MONTERREY, Mexico, 37Facultad de Ciencias Medicas, Universidad Nacional de Asunción, San Lorenzo, Paraguay, Asuncion, Paraguay, 38Facultad de Ciencias Medicas, Universidad Nacional de Asunción, San Lorenzo, Paraguay, Asunción, Paraguay, 39Hospital Nacional Edgardo Rebagliati Martins-EsSalud, Lima, Peru, Lima, Peru, 40Universidad Cientifica del Sur, Lima, Peru, 41Hospital Nacional Cayetano Heredia Universidad Peruana Cayetano Heredia, Lima, Peru, Jesús María, Peru, 42Hospital Docente Padre Billini, Santo Domingo, Distrito Nacional, Dominican Republic, 43Hospital de Clínicas, Facultad de Medicina, UDELAR, Montevideo, Uruguay, Montevideo, Uruguay, 44Médica Uruguaya, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay, Montevideo, Uruguay, 45Rheumatology Department, Hospital Clinic, Barcelona, Spain, Barcelona, Spain, 46Johnson & Johnson, Horsham, PA, USA, Ambler, PA, 47Johnson & Johnson, Spring House, PA, USA, Spring House, PA, 48Hospital General de México “Dr. Eduardo Liceaga”, Mexico City, Mexico, Mexico, Mexico

    Background/Purpose: Systemic lupus erythematosus (SLE) is a complex autoimmune disease with heterogeneous clinical manifestations. Evidence from high-income countries suggests that socioeconomic status (SES) and environmental…
  • Abstract Number: 2629 • ACR Convergence 2025

    Predictors of 30-day Readmissions in Pregnant Patients with Systemic Lupus Erythematosus: The Impact of Social Determinants of Health.

    Sandhya Kannayiram1, Yiyuan Wu2, Lisa Sammaritano3, Michael Lockshin4, Rich Caruana5, Ware Branch6, Jane Salmon3 and Bella Mehta7, 1Hospital for Special Surgery, Weill Cornell Medicine, New York, 2Weill Cornell Medicine, New York, NY, 3Hospital for Special Surgery, New York, NY, 4Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 5Microsoft, Redmond, WA, 6University of Utah Health Sciences Center, Salt Lake City, UT, 7Hospital for Special Surgery, Weill Cornell Medicine, Jersey City, NJ

    Background/Purpose: Social Determinants of Health (SDOH) are increasingly recognized as significant contributors to adverse outcomes in pregnant patients with SLE. This study aims to evaluate…
  • 1
  • 2
  • 3
  • …
  • 13
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology